Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ranitidine Use and Cancer Risk: Results From UK Biobank

Gastroenterology(2020)10.1053/j.gastro.2020.12.037Source: DataRank Database

Ranitidine Use and Cancer Risk: Results From UK Biobank is a research paper published in Gastroenterology (2020). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.75)OA: greenTopics (55)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Kelli O’Connell ORCID,Mengmeng Du ORCID,Robin B. Mendelsohn ORCID,Peter S. Liang ORCID,Lior Z. Braunstein ORCID

Live enrichment

PubMed:33385434 PMC:PMC8035224 OpenAlex:https://openalex.org/W3113793234

National Cancer Institute

Grant: K08 CA230162

National Cancer Institute

Grant: P30 CA008748

Medical Research Council

Grant: MC_PC_17228

Medical Research Council

Grant: MC_QA137853

National Institutes of Health

Grant: 5K08CA230162-05

Longitudinal Adherence to Colorectal Cancer Screening in the VA

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

FWCI

2.75

Citation Percentile

0.9%

Influential Citations

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8035224

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035224

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8035224

publisherhttps://api.elsevier.com/content/article/PII:S0016508520355888?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0016508520355888?httpAccept=text/plain

Fields of Study

Esophageal and GI PathologyWater Treatment and DisinfectionGastroesophageal reflux and treatmentsMedicine0301 basic medicine0303 health sciences03 medical and health sciencesAdultAgedFemaleHistamine H2 AntagonistsHumansMaleMiddle AgedNeoplasmsRanitidineRisk AssessmentRisk FactorsTime FactorsUnited Kingdom

MeSH Terms

AdultAgedFemaleUnited KingdomHistamine H2 AntagonistsHumansMaleMiddle AgedNeoplasmsRanitidineRisk FactorsTime FactorsRisk Assessment

Keywords

RanitidineMedicineBiobankFood and drug administrationPharmacologyBioinformaticsCanceromeprazoleepidemiologyNdmaAdultMaleTime FactorsMiddle AgedRisk AssessmentUnited KingdomHistamine H2 AntagonistsRisk FactorsNeoplasmsHumansFemaleAged

Sustainable Development Goals

SDG 0: Good health and well-being